Buch(gedruckt)#12007
Arbitrium et aequitas nel diritto amministrativo canonico
In: Pubblicazioni del Dipartimento di Scienze Giuridiche, Università degli Studi di Roma La Sapienza 4
Suchergebnisse
Filter
5 Ergebnisse
Sortierung:
Verfügbarkeit an Ihrem Standort wird überprüft
Dieses Buch ist auch in Ihrer Bibliothek verfügbar:
Buch(gedruckt)#22022
Libertà, dubbio, coscienza morale: l'eredità di un maestro : Arturo Carlo Jemolo (1891-1981) : atti del Convegno di studio, Roma, 22 aprile 2021
In: Un' anima per il diritto: andare più in alto 3
Verfügbarkeit an Ihrem Standort wird überprüft
Dieses Buch ist auch in Ihrer Bibliothek verfügbar:
Buch(gedruckt)#32020
Valetudo et religio: intersezioni fra diritto alla salute e fenomeno religioso : atti del convegno di studio : Roma, 4 aprile 2019
In: Collana di studi di diritto canonico ed ecclesiastico
In: Sezione ecclesiasticistica 32
Verfügbarkeit an Ihrem Standort wird überprüft
Dieses Buch ist auch in Ihrer Bibliothek verfügbar:
Open Access#42021
Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program
International audience ; INTRODUCTION: With the development of therapeutics and vaccine against Ebola Virus Disease, the question of post exposure prophylaxis for high risk contact emerged. Immunotherapies (monoclonal antibodies, mAbs) recently validated for treatment of infected patients appears to be good candidate to protect contacts.DESIGN: During the 10(th) EVD outbreak in the Democratic Republic of the Congo, we have administrated mAbs (Mab114 or REGN-EB3) to high and intermediate risk contact of Ebola Virus Disease patients.RESULTS: Overall, 23 non vaccinated contacts received mAbs after a median delay between contact and post exposure prophylaxis of 1 day (IQR 1,2). 14 days after the contact, all contacts were free of symptoms and all had negative RT-PCRCONCLUSION: Immunotherapies appears to be promising candidates to protect contacts of Ebola Virus Disease. Interaction with vaccine and larger study on efficacy need to be conducted.
BASE
Open Access#52021
Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program
International audience ; INTRODUCTION: With the development of therapeutics and vaccine against Ebola Virus Disease, the question of post exposure prophylaxis for high risk contact emerged. Immunotherapies (monoclonal antibodies, mAbs) recently validated for treatment of infected patients appears to be good candidate to protect contacts.DESIGN: During the 10(th) EVD outbreak in the Democratic Republic of the Congo, we have administrated mAbs (Mab114 or REGN-EB3) to high and intermediate risk contact of Ebola Virus Disease patients.RESULTS: Overall, 23 non vaccinated contacts received mAbs after a median delay between contact and post exposure prophylaxis of 1 day (IQR 1,2). 14 days after the contact, all contacts were free of symptoms and all had negative RT-PCRCONCLUSION: Immunotherapies appears to be promising candidates to protect contacts of Ebola Virus Disease. Interaction with vaccine and larger study on efficacy need to be conducted.
BASE